OCUL Earnings

Quarterly EPS
$-0.22
Q3 2024
$-0.29
Q4 2024
$-0.38
Q1 2025
$-0.39
Q2 2025
$-0.38
Q3 2025
$-0.29
Q4 2025
$-0.40
Q1 2026
$-0.35
Q2 2026
Latest Revenue13.5M
Latest Net Income-78763000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.3513.5M-78763000+0.1%+10.3%
Q1 2026-$0.4010.8M-88612000+0.8%-5.3%
Q4 2025-$0.2913.3M-64654000-22.4%+0.0%
Q3 2025-$0.3814.5M-69418000-5.7%-72.7%
Q2 2025-$0.3913.5M-67814000-18.1%-50.0%
Q1 2025-$0.3810.7M-64053000-27.6%+22.4%
Q4 2024-$0.2917.1M-48388000+15.4%+17.1%
Q3 2024-$0.2215.4M-36493000+2.3%-2,100.0%
Q2 2024-$0.2616.4M-43777000
Q1 2024-$0.4914.8M-64848000
Q4 2023-$0.3514.8M-29220000
Q3 2023-$0.0115.1M-516000
Ocular Therapeutix (OCUL) — Earnings